119 related articles for article (PubMed ID: 27814627)
1. Oxidative DNA and mitochondrial DNA change in patients with SLE.
Lee HT; Wu TH; Lin CS; Lee CS; Pan SC; Chang DM; Wei YH; Tsai CY
Front Biosci (Landmark Ed); 2017 Jan; 22(3):493-503. PubMed ID: 27814627
[TBL] [Abstract][Full Text] [Related]
2. Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus.
Lee HT; Lin CS; Lee CS; Tsai CY; Wei YH
Clin Exp Immunol; 2014 Apr; 176(1):66-77. PubMed ID: 24345202
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
4. The Role of Plasma Cell-Free Mitochondrial DNA and Nuclear DNA in Systemic Lupus Erythematosus.
Lee HT; Lin CS; Pan SC; Chen WS; Tsai CY; Wei YH
Front Biosci (Landmark Ed); 2022 Dec; 27(12):333. PubMed ID: 36624953
[TBL] [Abstract][Full Text] [Related]
5. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.
Hermansen ML; Hummelshøj L; Lundsgaard D; Hornum L; Keller P; Fleckner J; Fox B; Poulsen LK; Jacobsen S
Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117
[TBL] [Abstract][Full Text] [Related]
6. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
7. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
8. The role of hOGG1 C1245G polymorphism in the susceptibility to lupus nephritis and modulation of the plasma 8-OHdG in patients with systemic lupus erythematosus.
Lee HT; Lin CS; Lee CS; Tsai CY; Wei YH
Int J Mol Sci; 2015 Feb; 16(2):3757-68. PubMed ID: 25671815
[TBL] [Abstract][Full Text] [Related]
9. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
10. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
11. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
[TBL] [Abstract][Full Text] [Related]
12. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
Adel Y; Sadeq Y
Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829
[TBL] [Abstract][Full Text] [Related]
13. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
15. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Boghdadi G; Elewa EA
Rheumatol Int; 2014 Sep; 34(9):1217-23. PubMed ID: 24748505
[TBL] [Abstract][Full Text] [Related]
16. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
17. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
19. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Tam LS; Li EK; Lam CW
Ann Rheum Dis; 2006 Feb; 65(2):209-15. PubMed ID: 15975968
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
